ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Ambrosia Bio, an Israeli foodtech company, will collaborate with Ginkgo Bioworks to optimize and produce enzymes needed to manufacture D-psicose, more commonly known as allulose, from sugar and starch. Allulose is a rare natural sugar that has low caloric value and thus promises to impart flavor in foods while minimizing impact on blood glucose and insulin levels. Ambrosia, which recently came out of stealth mode, says it has a pipeline of related enzyme-led processes to make rare sugars and other specialty ingredients.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X